1. 2016
  2. Reprofiling using a zebrafish melanoma model reveals drugs cooperating with targeted therapeutics

    Fernandez Del Ama, L., Jones, M., Walker, P., Chapman, A., Braun, J. & Hurlstone, A. 5 May 2016 In : Oncotarget.

    Research output: Contribution to journalArticle

  3. Minimal Contribution of ERK1/2-MAPK Signalling towards the Maintenance of Oncogenic GNAQQ209P-driven Uveal Melanomas in Zebrafish

    Abdel Mouti, M., Dee, C., Coupland, S. E. & Hurlstone, A. 18 Apr 2016 In : Oncotarget.

    Research output: Contribution to journalArticle

  4. 2015
  5. α5β1 integrin recycling promotes Arp2/3-independent cancer cell invasion via the formin FHOD3

    Paul, N. R., Allen, J. L., Chapman, A., Morlan-Mairal, M., Zindy, E., Jacquemet, G., Fernandez Del ama, L., Ferizovic, N., Green, D. M., Howe, J. D., Ehler, E., Hurlstone, A. & Caswell, P. T. 14 Sep 2015 In : The Journal of Cell Biology. 10, 6, p. 1013-1031 18 p.

    Research output: Contribution to journalArticle

  6. Small Molecule Inhibition of ERK Dimerization Prevents Tumorigenesis by RAS-ERK Pathway Oncogenes.

    Hurlstone, A. & 20 others Herrero, A., Pinto, A., Colón-Bolea, P., Casar, B., Jones, M., Agudo-Ibáñez, L., Vidal, R., Tenbaum, S. P., Nuciforo, P., Valdizán, E. M., Horvath, Z., Orfi, L., Pineda-Lucena, A., Bony, E., Keri, G., Rivas, G., Pazos, A., Gozalbes, R., Palmer, H. G. & Crespo, P. 10 Aug 2015 In : Cancer cell. 28, 2

    Research output: Contribution to journalArticle

  7. Zebrafish: A New Companion for Translational Research in Oncology.

    Barriuso, J., Nagaraju, R. & Hurlstone, A. 8 Jan 2015 In : Clinical cancer research : an official journal of the American Association for Cancer Research.

    Research output: Contribution to journalArticle

  8. 2014
  9. Serum and glucocorticoid-regulated kinase 1 regulates neutrophil clearance during inflammation resolution

    Burgon, J., Robertson, A. L., Sadiku, P., Wang, X., Hooper-Greenhill, E., Prince, L. R., Walker, P., Hoggett, E. E., Ward, J. R., Farrow, S. N., Zuercher, W. J., Jeffrey, P., Savage, C. O., Ingham, P. W., Hurlstone, A. F., Whyte, M. K. B. & Renshaw, S. A. 15 Feb 2014 In : Journal of Immunology. 192, 4, p. 1796-1805 9 p.

    Research output: Contribution to journalArticle

  10. TP53 in the UV spotlight: A bona fide driver of melanoma

    Hurlstone, A. & Wellbrock, C. 2014 In : Pigment Cell and Melanoma Research.

    Research output: Contribution to journalArticle

  11. 2013
  12. Heterogeneous Tumor Subpopulations Cooperate to Drive Invasion

    Chapman, A., FernandezdelAma, L., Ferguson, J., Kamarashev, J., Wellbrock, C. & Hurlstone, A. 11 Nov 2013 In : Cell Reports.

    Research output: Contribution to journalArticle

  13. Constitutive rac activation is not sufficient to initiate melanocyte neoplasia but accelerates malignant progression

    Dalton, L. E., Kamarashev, J., Barinaga-Rementeria Ramirez, I., White, G., Malliri, A. & Hurlstone, A. Jun 2013 In : Journal of Investigative Dermatology. 133, 6, p. 1572-1581 9 p.

    Research output: Contribution to journalArticle

  14. Effect of SMURF2 targeting on susceptibility to MEK inhibitors in melanoma

    Smith, M. P., Ferguson, J., Arozarena, I., Hayward, R., Marais, R., Chapman, A., Hurlstone, A. & Wellbrock, C. 2 Jan 2013 In : Journal of the National Cancer Institute. 105, 1, p. 33-46 13 p.

    Research output: Contribution to journalArticle

Previous 1 2 3 4 Next

ID: 432143